Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
McKinsey
Colorcon
Merck
Baxter

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020522

See Plans and Pricing

« Back to Dashboard

NDA 020522 describes NUTROPIN AQ PEN, which is a drug marketed by Genentech and is included in one NDA. It is available from one supplier. Additional details are available on the NUTROPIN AQ PEN profile page.

The generic ingredient in NUTROPIN AQ PEN is somatropin. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the somatropin profile page.
Summary for 020522
Tradename:NUTROPIN AQ PEN
Applicant:Genentech
Ingredient:somatropin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020522
Suppliers and Packaging for NDA: 020522
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NUTROPIN AQ somatropin INJECTABLE;INJECTION 020522 NDA Genentech, Inc. 50242-074 50242-074-01 1 CARTRIDGE in 1 CARTON (50242-074-01) > 2 mL in 1 CARTRIDGE
NUTROPIN AQ NUSPIN somatropin INJECTABLE;INJECTION 020522 NDA Genentech, Inc. 50242-074 50242-074-01 1 CARTRIDGE in 1 CARTON (50242-074-01) > 2 mL in 1 CARTRIDGE

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/2ML (5MG/ML)
Approval Date:Dec 29, 1995TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/2ML (5MG/ML)
Approval Date:Apr 22, 2002TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5MG/2ML (2.5MG/ML)
Approval Date:Jan 3, 2008TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Medtronic
Johnson and Johnson
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.